Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial

Welter, Marie-Laure; Mallet, Luc; STIC study group

doi:10.1016/S1474-4422(17)30160-6

Scientific article

English

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial

ContributorsWelter, Marie-Laure; Mallet, Luc; STIC study group

CollaboratorsKrack, Paul; Pollak, Pierre

Published inThe Lancet Neurology, vol. 16, no. 8, p. 610-619

Publication date2017

Abstract

Deep brain stimulation (DBS) has been proposed to treat patients with severe Tourette's syndrome, and open-label trials and two small double-blind trials have tested DBS of the posterior and the anterior internal globus pallidus (aGPi). We aimed to specifically assess the efficacy of aGPi DBS for severe Tourette's syndrome.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de psychiatrie

Research groups

Médecine psychosomatique, neurosciences cliniques et mindfulness (690)

Citation (ISO format)

WELTER, Marie-Laure, MALLET, Luc. Anterior pallidal deep brain stimulation for Tourette’s syndrome: a randomised, double-blind, controlled trial. In: The Lancet Neurology, 2017, vol. 16, n° 8, p. 610–619. doi: 10.1016/S1474-4422(17)30160-6

Article (Published version)

Supplemental data

Identifiers

PID : unige:100665
DOI : 10.1016/S1474-4422(17)30160-6
PMID : 28645853

Additional URL for this publicationhttp://linkinghub.elsevier.com/retrieve/pii/S1474442217301606

Journal ISSN1474-4422

514views

4downloads

Creation21/11/2017 09:47:00

First validation21/11/2017 09:47:00

Update15/03/2023 07:40:13

Status update15/03/2023 07:40:13

Last indexation31/10/2024 09:10:41

Archive ouverte UNIGE

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial

Technical informations